Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Engineered coagulation factor VIII with enhanced secretion and coagulation potential for hemophilia A gene therapy

Yuji Kashiwakura, Yuto Nakajima, Kio Horinaka, Tiago J.S. Lopes, Yuma Furuta, Yuki Yamaguchi, Nemekhbayar Baatartsogt, Morisada Hayakawa, Yuko Katakai, Susumu Uchiyama, Osamu Nureki, Keiji Nogami, Tsukasa Ohmori

Blood blood.2025028481.

https://doi.org/10.1182/blood.2025028481

Published: 2025

Includes: Supplemental data

Journal Articles

Therapeutic base editing to generate a gain-of-function F9 variant for hemophilia B

Nemekhbayar Baatartsogt, Yuji Kashiwakura, Takafumi Hiramoto, Rina Ito, Rikako Sato, Yasumitsu Nagao, Hina Naruoka, Haruka Takata, Morisada Hayakawa, Khishigjargal Batjargal, Tomoki Togashi, Atsushi Hoshino, Taro Shimizu, Yusuke Sato, Tatsuhiro Ishida, Osamu Nureki, Tsukasa Ohmori

Blood blood.2024027870.

https://doi.org/10.1182/blood.2024027870

Published: 2025

Includes: Supplemental data

Journal Articles

Severe secondary deficiency of von Willebrand factor–cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure

Tomoko Ono, Jun Mimuro, Seiji Madoiwa, Kenji Soejima, Yuji Kashiwakura, Akira Ishiwata, Katsuhiro Takano, Tsukasa Ohmori, Yoichi Sakata

Blood (2006) 107 (2): 528–534.

https://doi.org/10.1182/blood-2005-03-1087

Published: 2006

Journal Articles

Phenotype Correction of Hemophilia A Mice with Adeno-Associated Virus (AAV) Vectors Carrying the B Domain Deleted Canine Factor VIII Gene.

Jun Mimuro, MD, Akira Ishiwata, Yuji Kashiwakura, Katsuhiro Takano, MD, Tsukasa Ohmori, MD, Seiji Madoiwa, MD, Hiroaki Mizukami, MD, Keiya Ozawa, MD, Yoichi Sakata, MD

Blood (2004) 104 (11): 3183.

https://doi.org/10.1182/blood.V104.11.3183.3183

Published: 2004

Journal Articles

Thrombophilic dysfibrinogen Tokyo V with the amino acid substitution of γ Ala327Thr: formation of fragile but fibrinolysis-resistant fibrin clots and its relevance to arterial thromboembolism

Akiei Hamano, Jun Mimuro, Motonori Aoshima, Takeyoshi Itoh, Noboru Kitamura, Susumu Nishinarita, Katsuhiro Takano, Akira Ishiwata, Yuji Kashiwakura, Kazuki Niwa, Tomoko Ono, Seiji Madoiwa, Teruko Sugo, Michio Matsuda, Yoichi Sakata

Blood (2004) 103 (8): 3045–3050.

https://doi.org/10.1182/blood-2003-07-2569

Published: 2004

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Engineered coagulation factor VIII with enhanced secretion and coagulation potential for hemophilia A gene therapy

Therapeutic base editing to generate a gain-of-function F9 variant for hemophilia B

Severe secondary deficiency of von Willebrand factor–cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure

Phenotype Correction of Hemophilia A Mice with Adeno-Associated Virus (AAV) Vectors Carrying the B Domain Deleted Canine Factor VIII Gene.

Thrombophilic dysfibrinogen Tokyo V with the amino acid substitution of γ Ala327Thr: formation of fragile but fibrinolysis-resistant fibrin clots and its relevance to arterial thromboembolism

Email alerts

ASH Publications

American Society of Hematology

Update search

Engineered coagulation factor VIII with enhanced secretion and coagulation potential for hemophilia A gene therapy

Therapeutic base editing to generate a gain-of-function F9 variant for hemophilia B

Severe secondary deficiency of von Willebrand factor–cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure

Phenotype Correction of Hemophilia A Mice with Adeno-Associated Virus (AAV) Vectors Carrying the B Domain Deleted Canine Factor VIII Gene.

Thrombophilic dysfibrinogen Tokyo V with the amino acid substitution of γ Ala327Thr: formation of fragile but fibrinolysis-resistant fibrin clots and its relevance to arterial thromboembolism

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only